Back in September of 2010 he was also names to the Board of another technology company that deals with urology and cancer therapies. Since his tenure at the FDA it sounds like von Eschenbach is returning to his roots with using his expertise in the clinical area of healthcare. BD Former FDA...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Wed, Jan 19 2011
Filed under:
Filed under: Medically Related, Pharma/FDA News, Cancer, FDA, Prostate Cancer, Pharmaceuticals, National Cancer Institute, enzymes, Durham, Viamet Pharmaceuticals, drug discovery, Andrew von Eschenbach
This is probably a good move to speed this process up since many pharmaceutical companies have and are looking at moving more trials to India. More information can be read here about the changing face of Pharma in reference to research and development. One more area to think about too is the use...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Fri, Sep 19 2008
Filed under:
Filed under: Medically Related, Pharma/FDA News, Genomics, drugs, Pharma, Cancer, clinical trials, Congress, DNA Testing, National Cancer Institute, Justice Department